Идёт набор NCT06336239

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

— Наблюдательное Cardiovascular Disease Type 2 Diabetes Mellitus

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально: Состояния в реестре: Cardiovascular Disease, Type 2 Diabetes Mellitus. Базовые параметры: от 18 лет · Все.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: Китай
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

The association between Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) is well established. Traditional risk factors for CVD and CKD are similar, with type 2 diabetes mellitus (T2DM) being the most prevalent risk factor. However, CKD is underdiagnosed and undertreated in patients with CVD. Further understanding of the combination of CKD in CVD patients is important to formulate prevention and treatment strategies for CVD patients and high-risk groups, reduce adverse events in CVD patients, and prevent progression of CKD to End Stage Renal Disease (ESRD).

Подробное описание

The PLACARD study will include approximately 3,000 patients presenting to the cardiology department with type 2 diabetes and cardiovascular disease. The aim of this study was to assess the prevalence of proteinuria (urinary ACR) in type 2 diabetic patients with different cardiovascular diseases, both inpatient and outpatient in the cardiology departments of secondary and tertiary hospitals in China. Participants will be recruited at 30 clinical centers for a period of six months.

Первичные конечные точки

The prevalence of albuminuria [Срок оценки: On the day of patients enrollment.]

Вторичные конечные точки (4)

Lthe prevalence of microalbuminuria and macroalbuminuria evels of microalbuminuria and macroalbuminuria [Срок оценки: On the day of patients enrollment.]
The prevalence of microalbuminuria and macroalbuminuria [Срок оценки: On the day of patients enrollment.]
To evaluate the related influence factors of albuminuria and the treatment patterns of CKD patients and non-CKD patients in cardiology departments; [Срок оценки: On the day of patients enrollment.]
Evaluate the management of patients with type 2 diabetes mellitus and cardiovascular disease across different levels of cardiology departments in hospitals. [Срок оценки: On the day of patients enrollment.]

Критерии участия

Критерии включения

Age ≥18 years old;
Diagnosed T2DM combined with ≥1 CVD (hypertension, coronary heart disease, atrial fibrillation, heart failure);
During the data collection period, they went to the outpatient clinic of the cardiology department of the research center, or received treatment in the cardiology department;
Ability to self-sign informed consent (electronic /paper).

Критерии исключения

Pregnant or lactating women;
Dialysis patients;
Other diseases that lead to elevated albuminuria, such as severe infection, confirmed primary glomerular disease, etc.;

. Malignant tumors being treated (surgery, chemotherapy, radiotherapy or targeted therapy);